FTC Issues Antitrust Warning Against ‘Improper’ Orange Book Patent Listings – Cooley LLP

The Hatch-Waxman Act provides that pharmaceutical manufacturers “shall” list in the Orange Book all patents that “could reasonably be asserted” if a …